𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neck recurrence after level I–IV or I–III selective neck dissection in the management of the clinically N0 neck in patients with oral squamous cell carcinoma

✍ Scribed by Mandeep S. Bajwa; Roddy McMillan; Owais Khattak; Mathew Thomas; Ojas P. Krishnan; Keith Webster

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
125 KB
Volume
33
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background

Controversy remains regarding extending the level I–III selective neck dissection (SND) to include level IV in the management of the clinically N0 (cN0) neck in patients with oral squamous cell carcinoma (OSCC).

Methods

Histologic and follow‐up data of 87 patients with previously untreated OSCC undergoing I–IV SND and 41 undergoing I–III SND between 2002 and 2006 were reviewed.

Results

Of the 98 I–IV SNDs performed, 4 had involvement of level IV. No relationship between tumor variables and level IV involvement was identified. Survival analysis failed to demonstrate a significant difference between I–III and I–IV SND in terms of developing neck recurrence in the 2 years following surgery.

Conclusions

Level I–III SND is effective management of the cN0 neck (when coupled with postoperative radiotherapy in selected cases) in patients with OSCC, although it is recommended that a larger prospective study be performed in this field. © 2010 Wiley Periodicals, Inc. Head Neck, 2010

📜 SIMILAR VOLUMES

Comparison of morbidity between sentinel
Comparison of morbidity between sentinel node biopsy and elective neck dissection for treatment of the n0 neck in patients with oral squamous cell carcinoma
✍ Karin Murer; Gerhard F. Huber; Sarah R. Haile; Sandro J. Stoeckli 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

## Abstract ## Background Sentinel node biopsy (SNB) has been proposed for staging of the cN0 neck in early oral/oropharyngeal squamous cell carcinomas (SCC). Because SNB is a minimally invasive procedure, it is thought to be associated with less morbidity than elective neck dissection. ## Method

Prospective trial to evaluate staged nec
Prospective trial to evaluate staged neck dissection or elective neck radiotherapy in patients with CT-staged T1-2 N0 squamous cell carcinoma of the oral tongue
✍ Sinead Brennan; June Corry; Stephen Kleid; Sandro Porceddu; Kally Yuen; Danny Ri 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

## Abstract ## Background A prospective study was undertaken to evaluate a policy of selective, single‐modality elective neck treatment in T1‐2, node‐negative oral tongue squamous cell carcinoma. ## Methods Where the primary tumor showed 1 of the 4 key pathological criteria (greater than 7 mm of

A Phase I/II trial of concurrent docetax
A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck
✍ Roy B. Tishler; Charles M. Norris Jr.; A. Dimitrios Colevas; Carolyn C. Lamb; Da 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

## Abstract ## BACKGROUND The authors conducted a Phase I/II study in patients with a poor prognosis who had locally advanced squamous cell carcinoma of the head and neck (SCCHN) and who were treated initially with induction chemotherapy. Patients were treated with weekly docetaxel and concurrent